Skip to main content
. Author manuscript; available in PMC: 2018 Aug 15.
Published in final edited form as: Biosens Bioelectron. 2017 Mar 27;94:632–642. doi: 10.1016/j.bios.2017.03.054

Figure 7. Cell viability results using MTS assay.

Figure 7

Cell viability curves comparing the drug response of (a) 4T1 breast cancer, (b) B16 melanoma cells with their Carboplatin-tolerant variants, and the drug response of (c) DU145 prostate cancer cells and Paclitaxel–resistant DU145 to Paclitaxel after 24 h of treatment. Error bars represent standard error of the mean (n=3).